APA

Kotsakis A., Kentepozidis N., Emmanouilidis C., Polyzos A., Agelidou A., Vaslamatzis M., Chandrinos V., Agelaki S., Vamvakas L., Kalbakis K., Katsaounis P., Stoltidis D., Nintos G., Hatzidaki D., Vetsika E. K., Mavroudis D. & Georgoulias V. (20151201). Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG). : Lung cancer (Amsterdam, Netherlands).

Chicago

Kotsakis A, Kentepozidis N, Emmanouilidis Ch, Polyzos A, Agelidou A, Vaslamatzis M, Chandrinos V, Agelaki S, Vamvakas L, Kalbakis K, Katsaounis P, Stoltidis D, Nintos G, Hatzidaki D, Vetsika E K, Mavroudis D and Georgoulias V. 20151201. Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG). : Lung cancer (Amsterdam, Netherlands).

Harvard

Kotsakis A., Kentepozidis N., Emmanouilidis C., Polyzos A., Agelidou A., Vaslamatzis M., Chandrinos V., Agelaki S., Vamvakas L., Kalbakis K., Katsaounis P., Stoltidis D., Nintos G., Hatzidaki D., Vetsika E. K., Mavroudis D. and Georgoulias V. (20151201). Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG). : Lung cancer (Amsterdam, Netherlands).

MLA

Kotsakis A, Kentepozidis N, Emmanouilidis Ch, Polyzos A, Agelidou A, Vaslamatzis M, Chandrinos V, Agelaki S, Vamvakas L, Kalbakis K, Katsaounis P, Stoltidis D, Nintos G, Hatzidaki D, Vetsika E K, Mavroudis D and Georgoulias V. Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG). : Lung cancer (Amsterdam, Netherlands). 20151201.